Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced the grant of the..
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that it has received notice to..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has announced today that it will hold..
Evgen Pharma Plc (LON:EVG) CEO Dr Stephen Franklin talks through the Preliminary Results Presentation for the year ended 31 March 2017. Evgen Pharma Plc is..
Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to..
Evgen Pharma PLC (LON:EVG) Chief Executive Officer Dr Stephen Franklin caught up with DirectorsTalk for an exclusive interview to discuss their final results for year-ended 31st..
Evgen Pharma Plc (LON:EVG) CEO Dr Stephen Franklin talks to DirectorsTalk about its final results for the year ended 31 March 2017. Stephen reminds us of..
Evgen Pharma plc (LON:EVG), the clinical stage drug development company focused on the treatment of cancer and neurological conditions, announced today its final results for the..
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced an update on its..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on cancer and neurological conditions, has today announced the signing of a services agreement with..
Northland Capital Partners Head of Research Vadim Alexandre caught up with DirectorsTalk for an exclusive interview to discuss Evgen Pharma PLC (LON:EVG) Q1: Now we’re..
Evgen Pharma Plc (LON:EVG) are the topic of conversation with Northland Capital Partners head of Research Vadim Alexandre. Vadim explains the importance of news that a..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced that the first patient..
Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced that it has received..
